Despite well-recognized biological importance, mass spectrometry (MS)-based glycomic identification of sulfo-, sialylated terminal glyco-epitopes on the N-glycans of various immune cell types remains technically challenging and rarely reported. Previous studies with monoclonal antibody have implicated a regulated expression of 6-sulfo-α2-6-sialyl LacNAc on B cells in peripheral lymph nodes and the circulating peripheral blood lymphocytes but its occurrence on leukemia cells or lymphomas have not been critically addressed. In this study, we have extended our previously developed MS-based sulfoglycomic platform by incorporating additional complementary analytical approaches in order to achieve a high sensitivity mapping and relative quantification of the detected sulfated glycotopes down to the level of defining their sialyl linkages. We showed that discovery mode sulfoglycomics and precise location of sulfate were best achieved by multimode MS analyses of fractionated, permethylated sulfated N-glycans. On the other hand, the relative degree of sulfation on individual N-glycans could be more efficiently inferred from the respective extracted ion chromatograms of native, non-sulfated and sulfated target N-glycans in single LC-MS/MS runs. The GlcNAc-6-O-sulfated α2-6-sialyl LacNAc, which constitutes the higher affinity ligand for the human inhibitory co-receptor of B cells, CD22, was found to be commonly carried on a range of complex type N-glycans from human CD19 + and CD4 + lymphocytes. We further showed that its occurrence on the most abundant α2-6-disialylated biantennary structure from the peripheral blood mononuclear cells of patients diagnosed as B-cell chronic lymphocytic leukemia varied within ±2-fold abundance from the mean value determined for isolated CD19+ lymphocytes and cultured B-CLL cells.
Introduction
Sulfation on various positions of terminal glyco-epitope (glycotope) carried on mammalian N-glycans is relatively less investigated or appreciated, compared to the better known cases of sulfated mucin type O-glycans and the sulfated glycosaminoglycans. Ironically, the SO 4 -4GalNAcβ1-4GlcNAcβ1-(4′-sulfo-LacdiNAc) carried on the complex type N-glycans of pituitary glycoprotein hormone (Baenziger and Green 1988) is in fact the first classic example of a specific sulfated glycotope contributing to recognition by a lectin receptor (Drickamer 1991) . This results in a relatively short circulatory half-life of secreted glycoprotein hormone such as lutropin due to their rapid clearance by the hepatic reticuloendothelial cell receptor (Fiete et al. 1991) . The same sulfated LacdiNAc glycotope has since been identified in several other secreted glycoproteins including the pro-opiomelanocortin (Skelton et al. 1992; Siciliano et al. 1993) , urokinase (Bergwerff et al. 1995) , carbonic anhydrase VI from submaxillary glands (Hooper et al. 1995) , Tamm-Horsfall glycoprotein (van Rooijen et al. 1998 ) and tenascin-R in cerebellum (Woodworth et al. 2002) , as well as more recently, by N-glycomic analysis of an ovarian carcinoma cell line (Yu et al. 2013 ), but each with unclear function.
While GalNAc-4-O-sulfate appears to associate specifically with LacdiNAc, the more ubiquitous sulfated glycotopes on N-glycans are the sulfated variations of the Galβ1-4GlcNAcβ-(LacNAc) unit, with and without additional sialylation and fucosylation. In that respect, only very few cases of rigorous structural identification have ever been carried out. Among these are the pioneering studies that demonstrated Gal-3-O-sulfate (3′-sulfo) and GlcNAc-6-O-sulfate (6-sulfo) on the LacNAc of N-glycans from human and bovine thyroglobulin (Spiro and Bhoyroo 1988) , and an α2-3-sialylated Gal-6-Osulfate (6′-sulfo) on recombinant human uterine tissue plasminogen activator from mouse epithelial cells (Pfeiffer et al. 1989 ). More than a decade later, both 3′-sulfo LacNAc and 6-sulfo LacNAc were identified on the N-glycans of bovine peripheral myelin glycoprotein P0 (Gallego et al. 2001) and mouse brain neural cell adhesion molecule (Geyer et al. 2001) , and 6-sulfo LacNAc on the N-glycans of erythropoietin expressed in baby hamster kidney cells (Kawasaki et al. 2001) , all of which resulting from work carried out on relatively abundant, purified glycoproteins. In contrast, definitive structural identification of these sulfated glycotopes on N-glycans isolated from human endothelial cells, leukocytes and monocytes central to the functioning of immune systems, have never been reported at glycomic level despite many immunological studies implicated their occurrence and functional relevance based on the use of monoclonal antibodies (Kannagi et al. 2009 ).
In the best studied case of lymphocyte homing mediated by sulfated glycotopes expressed on the high endothelial venule (HEV) of peripheral lymph node (Rosen 2004) , we were the first to show that 6-sulfo sialyl Le X , the preferred ligand of L-selectin, could be carried on the N-glycans of mouse lymph nodes in addition to the O-glycans (Mitoma et al. 2007) . It was then our first attempt at implementing a highly sensitive sulfoglycomic workflow based on mass spectrometry (MS) analysis of permethylated glycans (Khoo and Yu 2010) and we have since demonstrated its practical utilities in a range of other applications including zone pellucida (Pang et al. 2011) , eosinophils (Patnode et al. 2013a ) and B cells (Macauley et al. 2015; Wang et al. 2013) . In essence, our method relies on a facile fractionation and thus enrichment of the negatively charged, permethylated sulfated glycans from the overwhelmingly more abundant non-sulfated ones by passing the neutralized permethylation reaction mixtures directly through a mixed-mode solid phase extraction (SPE) cartridge . While mapping the occurrence of sulfated glycans/glycotopes by either MALDI-or nanoLC-MS/MS and determining the location of sulfate by observing diagnostic MS 2 ions (Cheng et al. 2015) can be readily accomplished within the detection sensitivity limit for the more abundant sulfated O-glycans, applications to the larger sulfated N-glycans and determination of sialyl linkages are more challenging. As in most other and our own previous studies, the α2-6-sialyl linkage for the sulfated glycans was only inferred from resistance to α2-3-sialidase digestion. Higher order of MS n analysis that may allow distinguishing the linkages (Ashline et al. 2014 ) is often not feasible when sample amount is limiting and has not been applied to sulfated sialyl glycans.
It is now well appreciated that a GlcNAc-6-O-sulfated version of α2-6-sialyl LacNAc constitutes a higher affinity ligand of human CD22, a sialic acid binding Ig-like lectin that functions as an inhibitory co-receptor of B cells. Intriguingly, the expression of this sulfated glycotope on naive B cells as defined by the mAb KN343 is downregulated upon activation and their migration into germinal center of peripheral lymph nodes (Kimura et al. 2007; Macauley et al. 2015) . It is unclear at present if such unmasking by downgrading a high to lower affinity cis-binding CD22 ligand on maturing B cells would confer any functional consequence, particularly in rendering a less CD22-attenuated state of signaling and/or more receptive to trans-binding. A putative role for CD22 in B-cell interaction with blood vessels and trafficking has actually been suggested since this KN343 glycotope was also found expressed on HEV of secondary lymphoid tissues, even more strongly than on B-cells (Kimura et al. 2007) . However, there is to date no direct evidence for the presence of 6-sulfo-α-2,6-sialyl LacNAc on human B cells and elsewhere, other than by flow cytometry and immuno-staining analysis using the mAb KN343, and our own MALDI-MS detection of the released sulfated sialylated glycans (Macauley et al. 2015) .
Although detection by mAb is convenient and sensitive, it does not provide information on the exact glycan carriers, which is important for any glycoproteomic attempt aiming at identifying the true physiological receptor glycoprotein ligands. It is also not possible to derive an indication of the degree of sulfation based on differential staining or flow cytometry analysis. In contrast, a nonbiased MS-based sulfoglycomic mapping is better suited to define a full range of sulfated glycan repertoire and their relative abundance, based on which the possible engagement of other siglecs/lectins in different pathophysiological context can be more purposefully investigated. We are particularly interested in asking how the engagement of CD22 may be affected by expression of either its cis or trans ligand in cases of B-cell chronic lymphocytic leukemia (CLL) and other lymphomas. This requires complementing our current sulfoglycomic platform with other add-ons to overcome several known technical limitations.
While permethylation enhances significantly the sensitivity of MS detection and facilitates MS n analysis (Haslam et al. 2006; Reinhold et al. 2013) , it generally suffers from inadequate chromatographic resolution on practically the only compatible stationary phase, i.e., reverse phase (RP) C18. A widely used alternative analytical approach for glycomics is microLC-MS/MS analysis of native glycans in negative ion mode on a poros graphitized carbon (PGC) column (Jensen et al. 2012; Ruhaak et al. 2009 ), or its chip-based format by nanoLC-MS/MS in positive ion mode (Hua et al. 2011; Ji et al. 2015) . Both affords adequate isomeric separation that can resolve structural features such as α2-3 versus 2-6 sialyl linkage.
However, most successful applications to date have been on O-glycans from mucins and N-glycans from cancer tissues or cultured cells. While the smaller and more abundant sulfated O-glycans are readily identified, detecting the sulfated N-glycans by PGC LC-MS/ MS was rarely reported (Ji et al. 2015) . It is anticipated that, unlike our sulfoglycomic approach based on permethylated glycans in which fraction enriched in sulfated glycans can be separately obtained and analyzed, simultaneous analysis of nonderivatized sulfated sialylated glycans in the presence of non-sulfated ones would be difficult and lacking in sensitivity. Nonetheless, the feasibility of detecting sulfated sialylated N-glycans isolated from leukocytes such as B cells by PGC LC-MS/MS analysis has not been investigated. In principle, not only would it allow resolution and thus identification of ±sulfated α2-3/2-6-sialyl LacNAc glycotopes, it also affords a more direct estimation of the degree of sulfation based on a single run.
In this work, we set out to investigate the sensitivity of a PGCbased nanoLC-MS/MS approach relative to our MALDI-and nanoLC-MS/MS analysis of permethylated glycans in either positive or negative ion mode. More importantly, the strengths and complementarity of each platform were tapped and integrated into establishing a sulfoglycomic pipeline most conducive to identify the occurrence of sulfo-, sialylated N-glycans and their relative abundance. We report here, for the first time, unequivocal MS-based identification of the 6-sulfo-α-2,6-sialyl LacNAc on the complex type N-glycans of human lymphocytes. We further demonstrate the technical feasibility in mapping the variable expression of this sulfated glycotope on the peripheral blood mononuclear cells (PBMC) from CLL patients at reasonable throughput.
Results
The first task in this work was to establish the best combination of MS-based analytical approaches for sulfoglycomics that could then be applied to map the occurrence of 6-sulfo-α-2,6-sialylated N-glycans on a panel of lymphocytes and PBMC derived from donors and CLL patients. For this purpose, we resorted initially to the use of two cell lines, NALM-6 and MEC-1 cells, which were defined, respectively, as a human precursor B cell established from an acute lymphoblastic leukemia (ALL) patient (Hurwitz et al. 1979 ) and a B-CLL cell from chronic B cell leukemia in prolymphocytoid transformation (Stacchini et al. 1999 ).
MALDI-MS and MS/MS analysis of permethylated N-glycans
MALDI-MS mapping is an essential first step to ascertain the occurrence and glycomic complexity of sulfated glycans in fractions that were devoid of the more abundant non-sulfated ones. In negative ion mode, the mono-sulfated N-glycans would ionize as [M-H] -, fully retaining the sulfate moiety, whereas the di-sulfated ones were more often detected after losing one of the two sulfates, essentially as [M-SO 3 -H] -at 14 u lower than the mono-sulfated counterparts.
This equates in mass value to an under-methylation, i.e., with an extra free OH group, due to the loss of sulfite and could be distinguished as "originally di-sulfated" only by virtue of their later elution off the SPE cartridge by higher salt and collected into the multiply sulfated fraction. For ease of comparison, the MALDI-MS profiles of the sulfated glycans in negative ion mode can be aligned against that of non-sulfated glycans in positive ion mode ( Figure 1A -C, see Supplementary data, Table SI for the glycosyl composition assignments for all detected major peaks including those by means of LC-MS). Since the latter ionized as [M+Na] + , the mass shift between a non-sulfated and mono-sulfated glycan of otherwise the same glycosyl composition would be +42 u (+SO 3 -CH 3 -Na, or +80-15-23 = 42 u). It was found that the complex type N-glycans of human B cells are relatively simple, the majority of which are core fucosylated, extended by multiple LacNAc (up to 6 at below m/z 5000) and variably sialylated. The most abundant component is usually the disialylated, core fucosylated biantennary structure. This N-glycosylation pattern is remarkably similar from batch to batch, for naïve human B cells, as well as the pre B and B-CLL cells examined here. It is obvious that each of these major components can carry one to two sulfates ( Figure 1A-C) although the MS signals for the di-sulfated N-glycans are fairly weak. More variable are signals attributed to the non-fucosylated N-glycans, which may have been derived from media or serum and are clearly absent in the mono-and di-sulfated N-glycans except for the ones accompanying the major disialylated biantennary glycans. This argues for a low level of incomplete core fucosylation. Conversely, a second Fuc residue that can potentially contribute to Lewis type glycotope other than the core fucosylation is only apparent on the mono-sialylated biantennary structures.
Direct MALDI-MS/MS analysis of the detected sulfated glycans in negative ion mode is by far the most straightforward mean to define the sulfated glycotopes. Since all fragment ions should retain the sulfate to be detected in negative ion mode, the most informative MS 2 ions afforded by the major mono-sulfated peak at m/z 3008 ( Figure 1D ) are the B ion at m/z 889, which identifies a terminal sulfo sialyl LacNAc and the ion at m/z 234 that has been found to be diagnostic of an internal 6-sulfo GlcNAc (Cheng et al. 2015; Patnode et al. 2013b) . Various neutral losses of the non-sulfated sialyl LacNAc antenna from the precursor were also detected while the B ion at m/z 2557 clearly locates the Fuc on the reducing terminal GlcNAc. On the mono-sialylated biantennary N-glycan at m/z 2647, similar MALDI-MS/MS showed that a sulfo LacNAc identified by the B ion at m/z 528 is additionally present alongside sulfo sialyl LacNAc ( Figure 1E ). The 3, 5 A ion at m/z 371 further indicated a 4-linked 6-sulfo HexNAc in support of the type 2 linkage of a LacNAc. This is expected to be a common trait for all other larger, variably sialylated N-glycans although sensitivity is a limiting factor to allow productive MS 2 to be acquired on each of these relatively weak molecular ion signals. Interestingly, a prominent B ion at m/z 702 confirms the presence of a fucosylated sulfo LacNAc glycotope for the monosialylated, difucosylated biantennary N-glycans detected at m/z 2821 ( Figure 1F ).
NanoLC-MS/MS analysis of permethylated sulfated N-glycans
A remarkable gain in MS1 signal-to-noise ratio for the permethylated sulfated N-glycans was obtained when only about half of the amount of mono-sulfated sample screened by MALDI-MS ( Figure 1B ) was subjected to RP C18 nanoLC-MS/MS analysis in negative ion mode ( Figure 2A ). Unfortunately, since the permethylated mono-sulfated N-glycans ionized as singly charged [M-H] species, their m/z values were over 3000 and could not be efficiently selected for productive MS 2 fragmentation. To allow MS 2 analysis, 100 μM NaOH was introduced into the mobile phase of the nanoLC-MS/MS system for data acquisition in positive ion mode instead. This resulted in a rather messy MS1 spectra as extensive heterogeneity, and hence spread in signal intensities, was induced . The three MALDI mass spectra shown here were aligned by these m/z offsets and the peaks connected vertically by blue lines to reflect the additional presence of sulfate(s) on the same N-glycans. Sulfated N-glycans with no obvious non-sulfated counterparts were additionally annotated in (B) and (C). The three major sulfated N-glycan peaks were directly subjected to MALDI-MS/MS on the TOF/TOF in negative ion mode (D-F) to confirm their terminal sulfated glycotopes by the B ions and the location of sulfate by the diagnostic low mass ions (m/z 234 for internal GlcNAc-6-S). For the monosialylated biantennary N-glycans, at least two alternative isomeric arrangements of the terminal sulfated glycotopes were present, as indicated.
via different combination of cation adducts ( Figure 2B diagnostic of the location of sulfate (inset). The averaged negative ion mode MS1 spectra for the singly charged monosulfated (A) and doubly charged disulfated (D) N-glycans both yielded molecular ions at a much better signal to noise ratio than those afforded by MALDI-MS (Fig 1B, C ). An unusual trisialylated disulfated biantennary N-glycans was reproducibly detected by both MALDI-MS (m/z 3355.6) and nanoLC-MS (m/z 1718.27) but unfortunately not strong enough to yield productive MS 3 for further confirmation of its structure.
sialyl LacNAc glycotope but lacking in ultimate sensitivity to define the location of sulfate. In contrast, in sample containing di-sulfated N-glycans, nanoLC-MS/MS analysis in negative ion mode allows efficient MS 2 /MS 3 to be acquired on the doubly charged precursors.
Despite the very weak MALDI-MS signal ( Figure 1B ), signal to noise ratio for the doubly charged [M-2 H] 2-molecular ions was excellent ( Figure 2D ). CID MS 2 on the more abundant di-sulfated N-glycans at m/z 1537.17 yielded a doubly charged B ion at m/z 1311.6, which localize the Fuc at the reducing end GlcNAc. Further HCD MS 3 on this ion produced the B ion at m/z 889, corresponding to sulfo sialyl LacNAc, and m/z 514 after further loss of the terminal sialic acid. Importantly, the 3,5 A ion at m/z 357 defined a type 2 chain while the diagnostic low mass ions at m/z 195, 234 and 264 confirmed the location of sulfate on the 6-position of an internal GlcNAc.
NanoLC-MS/MS analysis of native N-glycans on PGC
It is well appreciated that PGC-based LC can resolve many isomeric glycans including those differ by sialyl linkages and the reducing end anomeric configurations (Ruhaak et al. 2009 ). To avoid further splitting of each glycan into two peaks due to the latter factor, native glycans are normally reduced before subjecting to analysis. As expected, most of the MS1 peaks detected by nanoLC-MS/MS analysis of reduced, non-permethylated N-glycans on a PGC capillary column and auto-selected for MS 2 in negative ion mode are non-sulfated N-glycans, ranging from doubly to quadruply charged ( Figure 3A ). Only the most abundant mono-sulfated N-glycan could be readily detected at m/z 815.9 as triply charged [M-3H] 3-species although extracted ion chromatogram (XIC) plots could additionally extract out weak signal traces corresponding to other sulfated N-glycans ( Figure 3B ). In general, we found that having an extra sulfate contributed to slightly more retention and hence later elution of the sialylated N-glycans under the LC conditions used. By XIC, the mono-sulfated, disialylated biantennary structure could be resolved into a major earlier eluting peak and a minor later eluting peak. Its non-sulfated doubly charged counterpart at m/z 1184.4, on the other hand, was resolved into three peaks ( Figure 3C ). Since α2-6-sialylated structure is well known to elute earlier than its α2-3-sialylated isomer on PGC (Nakano et al. 2011; Pabst et al. 2007; Palmisano et al. 2013 ) and both the later eluting peaks were sensitive to α2-3-sialidase digestion, the XIC pattern is consistent with the major earlier eluting peak bearing two α2-6-sialylated antennae, whereas the later eluting one contained a mixed α2-3/2-6-sialylated antenna. Targeted MS 2 /MS 3 analysis on the α2-6-disialylated monosulfated isomer confirmed its overall core fucosylated, disiaylated biantennary N-glycan structure ( Figure 3D ) but fell short of producing fragment ions that would unambiguously define the location of sulfate. Despite its shortcomings in MS 2 /MS 3 to define the structural details of the sialyl 6-sulfo LacNAc glycotope, an advantage of this PGC-based nanoLC-MS/MS analysis over the RP-based nanoLC-MS/MS analysis of permethylated glycans is that it allows a direct relative quantification of the non-sulfated versus sulfated N-glycans of the same underlying structure resolved up to the level of sialyl linkages. Once established, the retention time information can be used in conjunction with accurate mass value to rapidly map the relative abundance of the ±sulfated α2-6-disialylated biantennary N-glycans by the respective XIC peak areas at high sensitivity (see later section, Figure 4E ). This would fall short of defining the absolute degree of GlcNAc-6-O-sulfation on α2-6-sialyl LacNAc since we could only home in on one single major disialylated biantennary structure without correcting for the different MS detection response factors.
Quantifying across all the sulfo α2-6-sialyl N-glycans would be preferable but not practically possible due to sensitivity and chromatographic resolution limitations of PGC-based nanoLC-MS analysis for the small percentage of larger multisialylated N-glycans.
Strategic workflow developed for mapping the occurrence of sulfo sialyl glycotope
We have shown from above studies that pinning down the structural details by a combination of nanoLC-MS/MS analysis either in positive or negative ion mode is possible, through which we could unambiguously identify the presence of 6-sulfo-α-2,6-sialyl LacNAc on the mono-and di-sulfated N-glycans from pre-B and B-CLL cells.
All things considered, a viable workflow applicable to >1 × 10 6 cells (Supplementary data, Figure S1 ) would start with half of the released glycan samples be permethylated, 10% of which spotted for each MALDI-MS and MS/MS analysis, and less than half that amount for each RP nanoLC-MS/MS run. Another half would be subjected to reduction and, after clean-up, suitably diluted aliquots, typically less than 5% of the reduced, non-permethylated glycans, would be used per PGC-based nanoLC-MS run to resolve the sialyl linkage isomers and to provide a simple mean to quantify their relative abundance. Based on experience accumulated from this work, we noted that if the initial screening of the permethylated sulfated glycans by MALDI-MS yielded no significant glycan signal above noise, further PGC nanoLC-MS analysis of the non-permethylated glycans would most likely also fail to detect any sulfated glycans.
Comparative mapping of the sulfo sialyl N-glycans of lymphocytes and PBMC
Using the strategy outlined above, we initiated the mapping of the 6-sulfo α2-6-sialyl LacNAc glycotope on PBMC derived from nine patients diagnosed as B-CLL, one patient as low grade B cell lymphoma (Supplementary data, Table SII), as well as one commercial source each of CD19 + and CD4 + cells isolated from PBMC of normal donors, in comparison with the data obtained on NALM-6 and MEC-1. Exemplary MALDI-MS data on two PBMC sources (PBMC#6 and #8) along with those of isolated lymphocytes are shown in Figure 4 , while a full dataset for all the 10 clinical samples is presented in Supplementary data, Figure S2 . Qualitatively, it is clear that each of the samples analyzed was found to carry the sulfated glycotope KN343 on a similar range of complex type N-glycans, and the disialylated biantennary, core fucosylated N-glycan was always the major peak although there were variations in the relative abundance of other N-glycans detected, mostly attributable to the degree of sialylation. The mono-sulfated N-glycan profile of CD19 + B cells ( Figure 4A ) is very similar to that observed for the pre-B and B-CLL cell lines ( Figure 1B ) but notably with the absence of the peak at m/z 2821 assigned as carrying an extra Fuc, which was detected for the CD4 + cells ( Figure 4B ) and eight out of 10 of the PBMC samples analyzed albeit at different level relative to the non-fucosylated disialylated biantennary structure at m/z 2834. PBMC#6 alone contained other N-glycans with 2 Fuc (m/z 3182, 3270, 3632, 4081, 4443, Figure 4C ) detected at significantly more abundant level, which may be related to its uniquely B-lymphoma instead of B-CLL status. On the other hand, an additional peak at m/z 3253, which carried an extra HexNAc likely to be a bisecting GlcNAc, was detected for the CD19 + cells and some but not all the PBMC samples. It was also not found on the CD4 + cells. Zooming in on the better resolved biantennary structures, PGC-based nanoLC-MS analyses ( Figure 4E , Supplementary data, Figure S3 ) revealed that α-2,6-sialylation was more prevalent than α-2,3-sialylation, to the extent that several samples (PBMC#2, 8, 9, 10) yielded predominantly single α-2,6-disialyl biantennary N-glycan, whereas the relative amount of mixed α-2,6/2,3-and α-2,3-disialylation varied. Two extremes of this variation in sialyl linkages were demonstrated by PBMC#6 versus #8 ( Figure 4E ) while the pattern of the rest was somewhat in between. Referring retrospectively to their initial typing and gating by mAb (Supplementary data, Table SII), 4 of the 10 PBMC samples analyzed contained as high as >92% of CD19 + cells, including PBMC#8 (96%). Another four ranged from 65% to 88%. In contrast, PBMC#6 contained only as few as 8% CD19 + cells, consistent with the patient being diagnosed as carrying low grade B-cell lymphoma. The five PBMC samples (#2, #5, #8, #9, #10) which had the highest % of CD19 + cells (>87%) were also found to be KN343 + in vast majority of their gated CD19 + cells (82% in one, 90-91% in 2, and >99% in another 2) although all were generally KN343 + .
Remarkably, this high % of KN343 + correlates well with our semiquantitative sulfo-abundance indices derived from the relative peak intensities of the sulfated versus total 2,6-disialyl biantennary N-glycans by direct single run PGC nanoLC-MS analysis of the native glycans, which also yielded the lowest value for the remaining PBMC#3, 4, 6 and 7 with only <60% CD19 + cells being KN343 + ( Figure 4F ). It would seem that low % of KN343 + contributed more to this lower level of sulfation on α-2,6-sialyl LacNAc than low % of CD19 + cells. PBMC#1 has about 70% CD19 + cells of which 70% was KN343 + . In contrast, although PBMC#7 has a higher % of CD19 + cells (84%), only 58% of which was KN343 + and its degree of sulfation on the target α-2,6-disialyl N-glycan was almost half that of PBMC#1. The mean value for the cultured NALM-6 and MEC-1 was slightly higher than that of the CD19 + cells, which , which were resolved into one or more peaks due to different sialyl linkages. For the most abundant disialylated Nglycans, the α2,6/α2,6-, α2,6/α2,3-, and α2,3/α2,3-disialylated, non-sulfated (green traces) and monosulfated (red traces) isomers could be readily resolved (C) and validated by further α2-3-sialidase digestion (lower panel).
averaged at around 12%. Variation across the 10 PBMC samples analyzed in this pilot study ranged from about 2× lower to 2× higher than this value. Notably, our sulfo-abundance index measured only the relative amount of GlcNAc-6-O-sulfation on α−2,6-sialyl LacNAc, which constitutes the KN343 epitope. Lower % of CD19 + cells may imply higher % of T cells or monocytes in the PBMC samples, all of which may also carry sulfated glycotopes but only that of a specific α-2,6-disialyl biantennary N-glycan structure would be considered. Figure S2 . Identification of α2,6-sialylated, 6-O-sulfated LacNAc (KN343 epitope) on the most abundant disialylated monosulfated biantennary N-glycans was based on further PGC nanoLC-MS analysis (E). The XIC peak areas of the mono-and non-sulfated α2,6-disialylated biantennary species (red and green traces, respectively, plotted at the same intensity scale, with the peaks for ±sulfo-α2,6-disialyl biantennary N-glycans vertically aligned) were used to calculate the relative abundance indices of the sulfated sialylated glycotope defined by KN343. A full set of similar XIC plots for all 10 PBMC samples analyzed, along with those of the two cell lines (NALM-6 and MEC-1), CD4 + T cells and CD19 + B cells can be found in Supplementary data, Figure S3 . Their calculated relative abundance indices, defined as the % of monosulfated/non+monosulfated α2,6-disialyl biantennary N-glycans (y-axis values) are shown here as bar chart (F). For each of the 10 PBMC samples, the % total of CD19 + cells stained as KN343 + by flow cytometry is also presented as a line chart for comparison (upper panel) .
Discussion
This work was driven largely by the need to develop an MS-based method that would allow quantitative mapping of a target sulfosialyl glycotope, KN343, on the N-glycans of isolated human immune cells. We showed that MALDI-MS/MS analysis of the sample fraction enriched in permethylated sulfated N-glycans in negative ion mode remains the most straightforward approach with sufficient sensitivity for discovery mode N-sulfoglycomics ( Figure 1, 4 and Supplementary data, Figure S1 ). It further allows direct MS 2 mapping of the sulfated glycotope and identification of the location of sulfate. Detection sensitivity would be further enhanced by negative mode reverse phase C18 nanoLC-MS/MS but MS 2 for defining the sulfated glycotopes could only be more efficiently performed on doubly charged disulfated N-glycans (Figure 2 ). The two cell lines used here indeed yielded sufficient amount of disulfated N-glycans for this purpose but not so for most biological/clinical samples including the PBMC and lymphocytes, when the available cell number/mass is limiting. In these immune cells, the level of sulfation is typically low with the total N-glycans in the mono-sulfated fraction estimated to be at only about 10% level of the predominant nonsulfated N-glycans (JY Chen and KH Khoo, unpublished data). Disulfated N-glycans would have occurred at even lower level than the monosulfated ones to allow confident detection in most cases. The normally low level of sulfation was also reflected by our PGC-based nanoLC-MS/MS analysis of the native, reduced N-glycans (Figure 3 ). It is currently not known if additional sulfate moiety may suppress signal intensity due to less favorable ionization amongst the overwhelming non-sulfated N-glycan pools. Discounting any differential response factor and relying on the accurate mass XICs, we have been able to plot and quantify the relative peak areas for the non-sulfated versus monosulfated N-glycans, albeit only for the most abundant species. From the dataset obtained (Supplementary data, Figure S3 ), it is clear that the disialylated biantennary N-glycan as defined by its accurate mass did not always give three distinctive, non-overlapping peaks that could be unambiguously assigned as α2,6/α2,6-, α2,6/α2,3-and α2,3/α2,3-, especially for the monosulfated ones which were often represented by weak signals. Nonetheless the first peak can always be identified as α2,6/α2,6-and therefore the presence of sulfate would make it a 6-sulfo α2,6-sialyl LacNAc, to be quantified against its non-sulfated counterpart. Due to low signal intensities, direct global discovery mode identification of sulfated Nglycans by this analytical approach remains difficult when not guided by prior sulfoglycomic knowledge. However, an advantage for these non-fractionated samples over permethylated derivatives is that relative quantification is based on peaks detected within one single run and thus would minimize experimental variations. Injecting the same proportion of aliquot from each of the released, reduced total N-glycan samples onto the PGC nanoLC-MS/MS system, the XIC ion intensities registered for the disialyl biantennary N-glycans did not differ much from one another (Supplementary data, Figure S3 ). This is not the case with MALDI-MS sampling of the permethylated, fractionated, monosulfated N-glycans (Supplementary data, Figure S2 ), whereby the ion intensities were affected by many factors including sample loss during derivatization, fractionation, MALDI-plate spotting and crystallization state. Fractionation allows the enriched sulfated N-glycans to be separately detected but also prevented them from being quantified within the same spectrum alongside nonsulfated N-glycans.
We concluded that a prior MS-based sulfoglycomic analysis of permethylated N-glycans would be both necessary and advantageous. It allows rapid assessment of sample complexity, quality and quantity. It also affords more reliable and informative MS/MS ions to define the sulfated glycotopes. For subsequent quantitative mapping against non-sulfated counterparts, direct targeted analysis of native glycans with PGC-based nanoLC-MS/MS would minimize all experimental variations, as well as potentially be more conducive to automation and high throughput analysis. It further allows resolving the sialyl linkages albeit restricted mostly to biand at most tri-antennary structures.
Our pilot study with the clinical PBMC samples has not only defined, for the first time, the relative expression level of sulfated glycotope KN343 on α2,6-disialylated biantennary glycans but also revealed significant variations in the relative amount of α2,6 versus α2,3-sialylation. It should be noted that non-sulfated α2,6-sialyl LacNAc can still function as a binding ligand of hCD22 albeit one with lower affinity than the GlcNAc-6-O-sulfated version (Crocker et al. 2007; Kimura et al. 2007 ). In contrast, conversion of α2,6-to α2,3-sialyl LacNAc would abolish binding completely. Since such changes in the relative abundance of sialyl linkages have been reported for both B and T cells upon activation (Antonopoulos et al. 2012; Bi and Baum 2009; Comelli et al. 2006; Marino et al. 2004; Naito et al. 2007; Toscano et al. 2007 ), any functional investigation on the immunological implications of downregulated sulfation on α2,6-sialyl LacNAc in the context of cis or trans CD22 binding should also duly take into considerations the changes in sialyl linkages. Our analytical approaches developed and reported here now enable such a systematic investigation into this intriguing biological process using a larger cohort size. Drawing conclusion from the data presented in this small scale pilot study would be premature and unwarranted. In fact, a more accurate profiling would necessitate venturing further into analyzing not the PBMC but isolated subsets of lymphocytes and monocytes. Even for cases tentatively diagnosed as B-CLL, the % of CD19 + cells within PBMC would not necessarily be high enough to be represented by unfractionated PBMC. Moreover, as we have identified in this work, CD4 + cells also carry the target 6-sulfo sialyl glycotopes with unknown expression level variations among healthy and leukemia individuals. The analytical task remains technically challenging but now more feasible than ever, with foreseeable further improvements in the attainable sensitivity.
Materials and Methods
Cells and chemical regents 
N-glycan preparation
Cell pellets (minimum cell number: 1 × 10 6 ) were harvested, washed with PBS at least three times and re-suspended in 200 μL of 1% Triton X-100 (Merck) in PBS, with 3 × 10 s sonication. Cell debris were removed by centrifugation at 13,000 rpm at 4°C for 10 min and a final concentration of 10 mM dithiothreitol (Sigma-Aldrich) and 50 mM iodoacetamide (Sigma-Aldrich) in 100 μL PBS were added sequentially to the supernatant, each followed by incubation at 37°C for 1 h. After this reduction/alkylation step, 44 μL of 100% trichloroacetic acid was added to a final concentration of 10% and left at −20°C for 30 min to get rid of the detergent by precipitation. The pellet collected by centrifugation at 13,000 rpm at 4°C for 30 min was washed with cold 100% acetone for at least three times, then redissolved in 50 mM ammonium bicarbonate buffer, pH 8.5, and digested with trypsin (Bovine Pancrease, TPCK-treated, SigmaAldrich, T-1426) at 37°C for 4 h.
The release of N-glycans and their subsequent derivatization and fractionation have been reported in our previous studies Khoo and Yu 2010) . Briefly, the tryptic digest was heated at 100°C for 10 min before adding 3U PNGase F (Roche) for the release of N-glycans at 37°C for 3 days. N-glycans were extracted from the tryptic peptide mixtures by passing through a Vac C18 Sep-pak cartridge (Waters, WAT054945) in 5% acetic acid before subjecting to permethylation by the NaOH/DMSO slurry method, and then loaded directly onto an Oasis Max cartridge (Water, 186,000,367) after careful neutralization of the reaction mixtures. The Oasis Max cartridge was equilibrated with 3 mL of 95% acetonitrile and 3 mL of 100 mM NH 4 OAc. The permethylated neutral glycan were eluted by 6 mL of 95% acetonitrile after washing by 6 mL of milli-Q water. Mono-sulfated glycans were eluted by 6 mL of 1 mM NH 4 OAc in 80% ACN. Higher sulfated glycans were eluted by 3 mL of 100 mM NH 4 OAc in 60% ACN, 20% methanol.
For PGC nanoLC-MS/MS analysis, N-glycans were reduced with an alkaline borohydride solution (250 mM NaBH 4 in 2 M NH 3 ) at 37°C for 2 h, and then quenched on ice by dropwise addition of 100% acetic acid until fizzling stopped. The reduced sample was applied directly onto a homemade 2 mL Dowex 50 W-X8 cation exchange mini column packed in a Pasteur pipet plugged with glass wool. The Dowex beads were prewashed and equilibrated in 5% acetic acids. The flow through and the following wash in 5 mL of 5% acetic acid were collected into a single tube and dried down. The borate was then co-evaporated from the mixture by 10% acetic acid in methanol. A portion of the native glycans was digested with 2U of α2,3-neuraminidase (Macrobdella decora, Recombinant, E. coli, Cat. 480,706, Merck) in 100 μL of 50 mM sodium acetate (pH 5.5) at 37°C overnight.
MALDI-MS and MS/MS
MALDI-MS analysis of non-, mono-and di-sulfated permethylated N-glycans was performed on a 4700 Proteomic Analyzer (Applied Biosystems). For non-sulfated N-glycans, permethylated samples in 50% acetonitrile were premixed 1:1 with 2,5-dihydroxybenzoic acid (DHB) matrix (10 mg/mL in 50% acetonitrile) and analyzed in the positive ion mode. For mono-and di-sulfated N-glycans, permethylated samples in 50% acetonitrile were premixed 1:1 with 3,4-diaminobenzophenone (DABP) matrix (10 mg/mL in 50% acetonitrile) and analyzed in the negative ion mode. Data acquisition comprised 40 subspectra of 50 laser shots, and laser energy was set at 4700. All MALDI CID MS/MS experiments in the negative ion mode were performed with a MALDI TOF/TOF 5800 system (AB Sciex). Data acquisition comprised 60 subspectra of 125 laser shot, and laser energy was set at 4200. The potential difference between the source acceleration voltage and the collision cell was set at 1 kV to obtain the desirable high energy CID fragmentation pattern. All glycan peaks were assigned and annotated manually.
NanoLC-MS and MS/MS analysis
Reverse phase (RP) nanoLC-MS/MS analysis of permethylated mono-sulfated N-glycans was performed on an EASY-nLC 1000 (TheromoFisher Scientific) coupled to an LTQ-Orbitrap Elite hybrid mass spectrometer (ThermoFisher Scientific). Samples were redissolved in 25% acetonitrile, applied onto a 75 μm × 25 cm nanoViper C18 column (ThermoFisher Scientific, P/N 164,535) and eluted at a constant flow rate of 300 nL/min, with a linear gradient of 30-75% acetonitrile (in 0.1% formic acid/100 μM NaOH) in 60 min, followed by a sharp increase to 90% acetonitrile in 12 min and then re-equilibrated by a sharp decrease to 0% acetonitrile and held for another 18 min. For each data dependent acquisition cycle, the full-scan MS spectrum (m/z 350-2000) was acquired in the Orbitrap at 120,000 resolution (at m/z 400) with automatic gain control target value of 1 × 10 6 . A target precursor inclusion list was applied to precede further selection of 20 of the most intense ions with an intensity threshold of 500 counts for collision-induced dissociation (CID). The automatic gain control target value and normalized collision energy applied for CID experiment were set as 10,000, 35%. All MS/MS data were interpreted manually. RP nanoLC-MS/MS analysis of permethylated di-sulfated N-glycan samples in negative ion mode was performed on a nanoACQUITY UPLC system (Waters) coupled to either an LTQOrbitrap Velos hybrid mass spectrometer (ThermoFisher Scientific) or an Orbitrap Fusion hybrid mass spectrometer system (ThermoFisher Scientific). All samples were redissolved in 25% acetonitrile, applied onto a 75 μm × 25 cm nanoACQUITY UPLC BEH130 column (Waters, P/N 186, 003, 545 ) and eluted at a constant flow rate of 300 nL/min. On the LTQ-Orbitrap Velos, a linear gradient of 5-40% and 40-80% acetonitrile (in 0.1% formic acid) in 20 min and 40 min, respectively, was applied, followed by a sharp increase to 85% acetonitrile in 12 min and then re-equilibrated by a sharp decrease to 5% acetonitrile and held for another 18 min. For each data dependent acquisition cycle, the full-scan MS spectrum (m/z 350-2000) was acquired in the Orbitrap at 60,000 resolution (at m/z 400) with automatic gain control target value of 5 × 10 6 . A target precursor inclusion list was applied to precede further selection of five of the most intense ions with an intensity threshold of gain control target value and normalized collision energy applied for CID experiment were set as 5000, 35%. For Orbitrap Fusion, a linear gradient of 1-30% and 30-80% acetonitrile (in 0.1% formic acid) in 5 min and 55 min, respectively, was applied, followed by a sharp increase to 90% acetonitrile in 10 min and then reequilibrated by a sharp decrease to 1% acetonitrile and held for another 20 min. For each data dependent acquisition cycle, the fullscan MS spectrum (m/z 800-2000) was acquired in the Orbitrap at 120,000 resolution (at m/z 400) with automatic gain control target value of 5 × 10 5 . A target precursor inclusion list was applied to precede further selection of target fragment ions with an intensity threshold of 1000 counts for higher-energy collisional dissociation (HCD) and collision-induced dissociation (CID). The automatic gain control target value and normalized collision energy applied for HCD and CID experiments were set as 10,000, 55%, and as 100,000, 40%, respectively. All MS/MS data were interpreted manually. PGC nanoLC-MS/MS analyses of reduced native N-glycans were performed on an Ultimate 3000 Autosampler coupled to an Aglient Technologies 1200 Series and an LTQ-Orbitrap Elite hybrid mass spectrometer (ThermoFisher Scientific). All samples were redissolved in double distilled water, applied onto a 75 μm × 15 cm Hypercarb column (ThermoFisher Scientific, P/N 35, 065 ) and eluted at a constant flow rate of 300 nL/min, with a liner gradient of 10-40% acetonitrile (in 0.04% ammonia) in 50 min, followed by a sharp increase to 90% in 15 min and then re-equilibrated by a sharp decrease to 10% acetonitrile and held for another 15 min. For each data dependent acquisition cycle, the full-scan MS spectrum (m/z 350-2000) was acquired in the Orbitrap at 120,000 resolution (at m/z 400) with automatic gain control target value of 1 × 10 6 . A target precursor inclusion list was applied to precede further selection of ten of the most intense ions with an intensity threshold of 500 counts for collision-induced dissociation (CID). The automatic gain control target value and normalized collision energy applied for CID was set as 10,000, 50%. All MS/MS data were interpreted manually.
Supplementary data
Supplementary data is available at Glycobiology online. 
